ERBB2 and breast carcinoma: The IC50 of 4D5Fv-PE25 against HER2-positive breast cancer cell line SK-BR-3 was found to be 11.29 ng/mL, significantly lower than the IC50 value of 3.00 μg/mL observed for HER2-negative breast cancer cell line MDA-MB-468.